Large gap with delayed quotes
Analysis date: 14.04.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 10.02.2026.
Interest
Very strong
Very strong
Four stars since 10.04.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 03.04.2026 at a price of 23.10.
Evaluation
Neutral
Neutral
Based on its growth potential and our own criteria, we believe the share price is currently fairly priced.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 10.04.2026.
4wk Rel Perf
19.46%
19.46%
The four-week dividend-adjusted overperformance versus STOXX600 is 19.46%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 10.02.2026.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.29%.
Mkt Cap in $bn
0.98
0.98
With a market capitalization <$2bn, MEDINCELL is considered a small-cap stock.
G/PE Ratio
16.71
16.71
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 1.6 often suggests the projected growth is a result of a base effect, meaning the company can often be in a turn around situation. In this case, the estimated PE is a better indicator of a stock's expected growth than the Long Term Growth (LT Growth).
LT P/E
7.46
7.46
The estimated PE is for the year 2029.
LT Growth
124.59%
124.59%
The annualized growth estimate is for the current year to 2029.
Avg. Nb analysts
4
4
Over the last seven weeks, an average of 4 analysts provided earnings per share estimates.
Dividend Yield
0.00%
0.00%
The company is not paying a dividend.
Beta
127
127
For 1% of index variation, the stock varies on average by 1.27%.
Correlation
0.29
0.29
Stock movements are strongly independent of index variations.
Value at Risk
6.03
6.03
The value at risk is estimated at EUR 6.03. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
03.10.2025
03.10.2025